{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:29:57Z","timestamp":1791955797887,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1136\/ard.61.12.1090","type":"journal-article","created":{"date-parts":[[2002,11,12]],"date-time":"2002-11-12T20:42:43Z","timestamp":1037133763000},"page":"1090-1094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Diagnostic associations in a large and consecutively identified population positive for anti-SSA and\/or anti-SSB: the range of associated diseases differs according to the detailed serotype"],"prefix":"10.1016","volume":"61","author":[{"given":"I","family":"Peene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Meheus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E M","family":"Veys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"De Keyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.61.12.1090_bib1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.60.12.1131","article-title":"Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of sera referred for ANA testing","volume":"60","author":"Peene","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.61.12.1090_bib2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/rheumatology\/32.5.396","article-title":"The molecular basis of the SSA\/Ro antigens and the clinical significance of their autoantibodies","volume":"32","author":"Ben-Chetrit","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.61.12.1090_bib3","series-title":"Manual of biological markers of disease","first-page":"1","article-title":"Clinical significance of autoantibodies to Ro\/SSA and La\/SSB","volume":"C4.1","author":"Tzioufas","year":"1996"},{"key":"10.1136\/ard.61.12.1090_bib4","first-page":"1450","article-title":"Heterogeneity of the anti-Ro (SSA) response in rheumatic diseases","volume":"21","author":"Lopez-Longo","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.12.1090_bib5","first-page":"130","article-title":"Fourth International Workshop on neonatal lupus syndromes and the Ro\/SSA-La\/SSB system","volume":"17","author":"Brucato","year":"1999","journal-title":"Clin Exp Rheum"},{"key":"10.1136\/ard.61.12.1090_bib6","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1172\/JCI117145","article-title":"Molecular composition of Ro small ribonucleoprotein complexes in human cells. Intracellular localization of the 60- and 52-kD proteins","volume":"93","author":"Kelekar","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.61.12.1090_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2249.1995.tb03728.x","article-title":"Purification of antigenically intact Ro ribonucleoproteins: biochemical and immunological evidence that the 52-kD protein is not a Ro protein","volume":"100","author":"Boire","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.61.12.1090_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/1529-0131(199902)42:2<199::AID-ANR1>3.0.CO;2-1","article-title":"Fine specificity of the autoimmune response to the Ro\/SSA and La\/SSB ribonucleoproteins","volume":"42","author":"Scofield","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.12.1090_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3","article-title":"et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I Precision, sensitivity and specificity","volume":"42","author":"Tan","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.12.1090_bib10","first-page":"1897","article-title":"Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus","volume":"23","author":"Zimmerman","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.12.1090_bib11","first-page":"860","article-title":"Recombinant 52k Da Ro(SSA) ELISA detects autoantibodies in Sj\u00f6gren's syndrome that go undetected by conventional serologic assays","volume":"24","author":"McCauliffe","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.12.1090_bib12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.12.1090_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.12.1090_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.12.1090_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","article-title":"Classification criteria for the idiopathic inflammatory myopathies","volume":"9","author":"Targoff","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.61.12.1090_bib16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","article-title":"Preliminary criteria for the classification of Sj\u00f6gren's syndrome: results of a prospective concerted action supported by the European Community","volume":"36","author":"Vitali","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.12.1090_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.1780330307","article-title":"Dissociation of immunoresponses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sj\u00f6gren's syndrome","volume":"33","author":"Ben-Chetrit","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.12.1090_bib18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.1996.00440120079007","article-title":"Antinuclear antibody testing. A study of clinical utility","volume":"156","author":"Slater","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.61.12.1090_bib19","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/art.1780400910","article-title":"Cinical significance of antinuclear antibodies","volume":"40","author":"Emlen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.12.1090_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2249.1991.tb05780.x","article-title":"Detection and occurrence of the 60-and 52-kD Ro (SS-A) antigens and of autoantibodies against these proteins","volume":"86","author":"Slobbe","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.61.12.1090_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","article-title":"Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy","volume":"109","author":"Rutjes","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.61.12.1090_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/jaut.1998.0265","article-title":"The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies","volume":"12","author":"Frank","year":"1999","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.61.12.1090_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.61.12.1090_bib24","first-page":"403","article-title":"Undifferentiated connective tissue disease with antibodies to Ro\/SSA: clinical features and follow up of 148 patients","volume":"19","author":"Cavazzana","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.61.12.1090_bib25","first-page":"205","article-title":"Determination of the fine specificity of antinuclear antibodies in connective tissue diseases using a multiparameter line immunoassay (LIA) based on recombinant proteins","volume":"17","author":"Meheus","year":"1999","journal-title":"Clin Exp Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724091672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724091672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.61.12.1090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:58:35Z","timestamp":1737349115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724091672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S0003496724091672"],"URL":"https:\/\/doi.org\/10.1136\/ard.61.12.1090","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic associations in a large and consecutively identified population positive for anti-SSA and\/or anti-SSB: the range of associated diseases differs according to the detailed serotype","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.61.12.1090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Copyright 2002 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}